Intrapatient viral diversity and treatment outcome in patients with genotype 3a hepatitis C virus infection on sofosbuvir-containing regimens. [electronic resource]
Producer: 20181015Description: 344-353 p. digitalISSN:- 1365-2893
- Antiviral Agents -- therapeutic use
- Carbamates -- therapeutic use
- Genetic Variation
- Genotype
- Hepacivirus -- classification
- Hepatitis C, Chronic -- drug therapy
- Heterocyclic Compounds, 4 or More Rings -- therapeutic use
- Humans
- Ribavirin -- therapeutic use
- Sofosbuvir -- therapeutic use
- Treatment Outcome
- Viral Nonstructural Proteins -- genetics
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.